Conservative Management Up for Low-Risk Prostate Cancer in Veterans
Among US veterans with low-risk prostate cancer, use of conservative management increased from 2005 to 2015, according to a research... Read More
Among US veterans with low-risk prostate cancer, use of conservative management increased from 2005 to 2015, according to a research... Read More
Metformin use is associated with prolonged survival among men with advanced prostate cancer receiving androgen deprivation therapy (ADT), according to... Read More
Prostvac-V/F, an investigational prostate cancer (PCa) vaccine regimen, does not improve overall survival among men with asymptomatic or minimally symptomatic... Read More
Men with advanced prostate cancer (PCa), especially those with castration-resistant prostate cancer (CRPC), have an elevated risk of disease-related complications... Read More
For prostate cancer survivors, dysfunction due to treatment side effects has a bidirectional association with emotional distress, according to a... Read More
Enzalutamide delays metastasis in men with non-metastatic castration-resistant prostate cancer (CRPC) without worsening health-related quality of life (HRQoL) and significantly... Read More
Men who smoke at the time of radical prostatectomy or radiation therapy for localized prostate cancer (PCa) have higher risks... Read More
Node-positive prostate cancer is becoming more widespread for reasons other than changes in screening practices, Christopher P. Filson, MD, MS,... Read More
Testosterone replacement therapy (TRT) for men with a history of prostate cancer does not increase recurrence rates following radical treatment... Read More
Prostatic Urethral Lift (PUL) is a safe and effective treatment for obstructive middle prostatic lobes in men with benign prostatic... Read More